Roche Antibody Testing Continues Expansion
Roche Diagnostics in Indianapolis says its antibody test for the novel coronavirus is now operational at 20 commercial and hospital labs across the U.S. The company says it intends to get the testing system to more than 200 locations within the next several weeks.
The Elecsys Anti-SARS-CoV-2 antibody test received Emergency Use Authorization from the FDA earlier this month.
Roche says the test is designed to help determine if someone has been exposed to the SARS-CoV-2 virus and if they have developed antibodies against it.
“Reliable, high-quality antibody testing is essential to help us overcome this pandemic and will play an important role in getting people back to work,” said Matt Sause, president and chief executive officer of Roche Diagnostics North America.
Roche is working with North Carolina LabCorp (NYSE: LH), a commercial laboratory company, to make the test available.
The company says LabCorp and other commercial labs will be able to perform more than two million of the tests per week by June.
Roche says it is scaling global production to expand broader access.